Eng

Xinhua News | 2024 Zhongguancun Forum opens in Beijing to focus on cutting-edge technologies
XINHUA
發布於 04月25日06:56 • Fang Dong,Gao Kang,Wen Jinghua,Zhang Manzi,baige（yidu）,Zhou Saang,Tian Li

The 2024 Zhongguancun Forum (ZGC Forum) kicked off on Thursday in Beijing and will focus on cutting-edge fields from artificial intelligence to life sciences and new materials during the five-day session ending next Monday. #XinhuaNews

Eng

更多 Eng 相關文章

Russia's Progress MS-27 cargo spacecraft docks at ISS
XINHUA
Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion Protein (IBI363) in Melanoma, Colorectal Cancer and other Solid Tumors at the 2024 ASCO Annual Meeting
PR Newswire (美通社)
Asia Album: Travel with China's train at Asia Pacific Rail 2024
XINHUA
Han Wei clinches 4th championship as Taklimakan Rally concludes
XINHUA
GenFleet Therapeutics Announces Efficacy & Safety Result from Phase II Trial for First-line NSCLC Treatment in KROCUS Study, fulzerasib (KRAS G12C Inhibitor) in Combination with cetuximab, in a Late-breaking Abstract at the Oral Presentation of 2024 ASCO Annual Meeting
PR Newswire (美通社)
Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib（ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meeting
PR Newswire (美通社)
CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC
PR Newswire (美通社)
GLOBALink | Vlog: "Ancient yet modern, truly impressive" - A dialogue with foreign tourists in Xi'an
XINHUA
Chinese State Councilor emphasizes ensuring children's health, happiness
XINHUA
China's food security law takes effect
XINHUA
A traumatized Iraqi child struggles to overcome hardships after years of violence
XINHUA
"Panda of the birds" seen nesting and breeding in N China reserve
XINHUA
Innovent Presents at the 2024 ASCO Annual Meeting on Clinical Data of anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Pancreatic Cancer or Biliary Tract Cancer
PR Newswire (美通社)
Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO
PR Newswire (美通社)

查看更多 XINHUA 的文章

Russia's Progress MS-27 cargo spacecraft docks at ISS
XINHUA
Asia Album: Travel with China's train at Asia Pacific Rail 2024
XINHUA
Han Wei clinches 4th championship as Taklimakan Rally concludes
XINHUA
GLOBALink | Vlog: "Ancient yet modern, truly impressive" - A dialogue with foreign tourists in Xi'an
XINHUA
Chinese State Councilor emphasizes ensuring children's health, happiness
XINHUA
0 0